Sign In
Buy ICAD
$3.87
+0 (+0%)
At Close: Oct 16, 2025
5 Growth Stocks to Buy Now
04:44pm, Friday, 27'th May 2022
EPS estimates are generally a strong indication of future growth. That's just one part of finding reliable growth stocks.
iCAD to Present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 17th, 2022
03:30pm, Thursday, 12'th May 2022
NASHUA, NH / ACCESSWIRE / May 12, 2022 / iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will pres
iCAD, Inc. (ICAD) CEO Stacey Stevens on Q1 2022 Results - Earnings Call Transcript
08:00pm, Wednesday, 11'th May 2022
iCAD, Inc. (NASDAQ:ICAD ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Stacey Stevens – President & Chief Executive Officer Charles Carter – Chief Financial Office
Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Wednesday, 11'th May 2022
Icad (ICAD) delivered earnings and revenue surprises of -40% and 0.37%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference
04:21pm, Wednesday, 09'th Mar 2022 GlobeNewswire
NASHUA, N.H., March 09, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the virtual 32nd Annual Oppenheimer Healthcare Conference , taking place March 15-17, 2022.
iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference
11:21am, Wednesday, 09'th Mar 2022
NASHUA, N.H., March 09, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company
iCAD, Inc. (ICAD) CEO Michael Klein on Q4 2021 Results - Earnings Call Transcript
10:50pm, Monday, 28'th Feb 2022
iCAD, Inc. (ICAD) CEO Michael Klein on Q4 2021 Results - Earnings Call Transcript
Icad (ICAD) Reports Q4 Loss, Lags Revenue Estimates
08:39pm, Monday, 28'th Feb 2022
Icad (ICAD) delivered earnings and revenue surprises of -54.55% and 0.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28
04:05pm, Monday, 14'th Feb 2022
NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will
7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now
02:53pm, Thursday, 06'th Jan 2022
These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds. The post 7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now appeared
iCAD, Inc. (ICAD) CEO Michael Klein on Q3 2021 Results - Earnings Call Transcript
12:12am, Wednesday, 10'th Nov 2021
iCAD, Inc. (ICAD) CEO Michael Klein on Q3 2021 Results - Earnings Call Transcript
Icad (ICAD) Reports Q3 Loss, Misses Revenue Estimates
09:21pm, Tuesday, 09'th Nov 2021
Icad (ICAD) delivered earnings and revenue surprises of 0.00% and -0.52%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)
08:00am, Thursday, 07'th Oct 2021
Leading-edge AI solution for 2D mammography enhances cancer detection performance for clinicians, with improved sensitivity, specificity, and processing times over previous versions
iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography
08:00am, Wednesday, 29'th Sep 2021
Latest generation of ProFound AI Risk offers greater accuracy and ethnically inclusive precision screening
iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact
02:46pm, Thursday, 09'th Sep 2021
Leading experts to discuss novel AI technology helping them overcome pandemic-related challenges including substantial mammography backlog Leading experts to discuss novel AI technology helping them o
